viewAdmedus Ltd

Admedus appoints Steve Denaro to the board

The company has developed heart valve technology and has an immunotherapy business.

empty board room seats
Shares in the company last traded at 13.5 cents

Admedus Ltd (ASX:AHZ) has appointed experienced tax professional Streve Denaro to sit on its board as a non-executive director and company secretary.

The chartered accountant and registered tax agent has more than 30 years of senior and board level experience across publicly listed companies serving at CFO, director and company secretary.

Admedus’s chairman John Seaberg said: “We are very pleased to welcome Steve to the Admedus board.

“His comprehensive experience in financial management and deep understanding of the Australian and global financial regulatory environments make him a valuable addition to the company’s leadership as we pursue exciting new strategic opportunities.”

READ: Admedus completes placement to strategic cornerstone investor Star Bright Group

Substantial investor, Star Bright Holding Ltd and its associated companies recently increased its shareholding to 19.99%.

The ownership is a result of participation in 2018 capital raisings which came in the form of share placements.

Admedus is also negotiating with Star Bright in respect of a long-term funding agreement for Admedus Immunotherapies.

The two parties entered a memorandum of understanding (MoU) for a 60% share of the vaccines business for an initial investment of $18 million.

Quick facts: Admedus Ltd

Price: 0.094 AUD

Market: ASX
Market Cap: $55.54 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Admedus Ltd named herein, including the promotion by the Company of Admedus Ltd in any Content on the Site, the Company receives from said...



Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read